Bruker Corporation Common Stock (BRKR)

FairStock Score: 46/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for durable businesses at a sensible price. Bruker makes sophisticated scientific instruments; its service and lifecycle support might create some recurring revenue, but the recent numbers do not yet show a moat translating into consistent profits. In fiscal 2025, the year ended 2025-12-31, revenue was $3.4B and net income was a loss of $8.6M, with diluted EPS of -$0.15. That is a sharp reversal from fiscal 2024, the year ended 2024-12-31, when net income was $113.1M, and fiscal 2023, the year ended 2023-12-31, when net income was $427.2M. In the latest filed quarter, fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $838.5M but net income was -$52.0M. Fiscal Q1 2026, the quarter ended 2026-03-31, did earn $14.4M, so results are uneven. Financial health is mixed: debt-to-equity is 0.76, FairStock's Altman Z-Score is 2.33, and its Piotroski F-Score is 3/9. Free cash flow over the trailing twelve months was $64.5M, only a 0.8% yield at the 2026-10-13 close of $56.19, while FairStock's EV/EBITDA is 37.76 and P/B is 3.60. The Lynch category is turnaround, loss in the latest year after earlier profits. A turnaround can pay, but at this price I see a thin margin of safety and want evidence of durable profit and cash recovery.

In plain English: Bruker makes scientific instruments and related services. The business has recently swung from profits to losses, and it generates only a small amount of cash compared with its size. Based on those numbers, the stock price looks full rather than cheap, though it could improve if the losses reverse.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer